Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Zenith Captal Common Stock V.ZENI.P

Healthcare Biotechnology
Zenith Capital Corporation does not have significant operations. It engages in identification and evaluation of assets or a business and to negotiate an acquisition of, or participation in, a business subject to receipt of shareholders. Zenith Capital Corporation was incorporated in 2019 and is headquartered in West Vancouver, Canada.

Recent & Breaking News (TSXV:ZENI.P)

    Canadian Investment Regulatory Organization Trade Resumption - ZENI.P

    Canada NewsWire March 7, 2025

    IIROC Trading Halt - ZENI.P

    Canada NewsWire March 9, 2023

    IIROC Trading Resumption - ZENI.P

    Canada NewsWire February 7, 2023

    IIROC Trading Halt - ZENI.P

    Canada NewsWire September 8, 2022

    Zenith Epigenetics (TSXV:ZENI.P) to collaborate with Astellas Pharma on cancer treatment

    Trevor Abes  April 22, 2021